There were no clear trends in the risk of this cancer with time since first treatment, but there was a positive trend with total cumulative dose and number of cycles of clomiphene, with the first being significant ( P for linear trend=0.034).
← all excerpts
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.
1
—
—